假体周围关节感染患者抗生素治疗时长:平衡证据与经验
假体周围关节感染(PJI)是关节置换术后严重并发症,随人口老龄化和合并症增加发病率预计上升。本文评述现有文献,讨论不同手术策略下抗生素疗程,认为部分情况下较短疗程和早期口服转换可同样有效,但研究异质性限制结果推广,需进一步高质量标准化研究。
要点
- 清创、抗生素和假体保留(DAIR)联合彻底清创和生物膜活性药物时,6至8周全身抗生素疗程可能足够。
- 二期翻修中抗生素骨水泥间隔物允许更短抗生素疗程,单期翻修在有利条件下也可能需要较短方案。
- 所有手术方式中早期转为口服抗生素与延长静脉治疗可能同样有效,对患者和医疗系统有优势。
核心结论
- 近期证据提示较短抗生素方案和早期转为口服抗生素在某些情况下可同样有效。
- 研究异质性(感染和结局定义不一、样本量小、手术技术多样)限制结果推广性。
- 需要进一步高质量标准化研究以确定不同手术策略下最佳抗生素疗程。
- 多学科方法平衡抗生素疗效与潜在风险对改善结局至关重要。
研究设计与样本
- 本文为评述(annotation),目的是回顾当前关于PJI管理中抗生素治疗时长的文献并思考未来应研究方向。
主要发现
- 延长抗生素治疗可能不改善结局,并增加毒性及抗菌药物耐药风险。
- DAIR联合彻底清创和使用生物膜活性药物时,6至8周全身抗生素疗程可能足够。
- 二期翻修中使用抗生素骨水泥间隔物允许更短抗生素疗程,单期翻修在有利条件下也可能需要较短方案。
- 所有手术方式中早期转为口服抗生素与延长静脉治疗可能同样有效,对患者和医疗系统有优势。
临床怎么用
- 原文未据此给出推荐。
局限性
- 研究异质性包括感染和结局定义不一、样本量小和手术技术多样,限制结果推广性。
- 需要进一步高质量标准化研究以确定不同手术策略下最佳抗生素疗程。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Periprosthetic joint infection (PJI) remains a severe complication after arthroplasty, with rates expected to rise given the ageing population and their increasing rates of comorbidity. Management is challenging due to the interplay between surgical strategies, antibiotic treatment, and patient-specific factors. Traditionally, prolonged courses of antibiotics were used; however, extending therapy may not improve outcomes, and raises risks such as toxicity and antimicrobial resistance. Recent evidence suggests that shorter antibiotic regimens and early transition to oral antibiotics can be equally effective in some circumstances. For patients managed with debridement, antibiotics, and implant retention, a six- to eight-week systemic course of antibiotics may be sufficient when combined with thorough debridement and the use of biofilm-active agents. In two-stage revision, the use of antibiotic-loaded cement spacers permits even shorter lengths of antibiotic treatment, while single-stage revisions may also require shorter regimens under favourable conditions. Early transition to oral antibiotics can also be equally effective compared with prolonged intravenous therapy across all surgical procedures with advantages for patients and healthcare systems. Despite these promising findings, the heterogeneity of studies (including variable definitions of infection and outcome, small sample sizes and diverse surgical techniques) limits the generalizability of the results. Further high-quality, standardized research is required to determine the optimal length of antibiotic treatment in different surgical strategies. Meanwhile, a multidisciplinary approach which carefully balances the efficacy of antibiotic treatment with potential risks is essential for improving outcomes in these patients. The aim of this annotation was to review the current literature dealing with the length of antibiotic treatment in the management of PJI, and to consider the avenues that should be investigated in the future.
引用
- Kennedy IW, Boscainos P, Haddad FS, et al. The length of antibiotic treatment in patients with periprosthetic joint infection : balancing evidence and experience. Bone Joint J. 2025. PMID: 41173043. doi:10.1302/0301-620X.107B11.BJJ-2025-0374.R2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。